BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Ding Y, Guo N, Wang S. MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation. Front Immunol 2019;10:172. [PMID: 30792719 DOI: 10.3389/fimmu.2019.00172] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 19.3] [Reference Citation Analysis]
Number Citing Articles
1 Han X, Bi L, Wu Y, Yan J, Wu X, Zheng R, Sun Y, Zhang H, Wang Z, Wang Y, Zhang H. Genetically engineered exosomes for targetedly preventing premetastatic niche formation and suppressing postoperative melanoma lung metastasis. Nano Today 2022;46:101597. [DOI: 10.1016/j.nantod.2022.101597] [Reference Citation Analysis]
2 Zhao Y, Bai Y, Shen M, Li Y. Therapeutic strategies for gastric cancer targeting immune cells: Future directions. Front Immunol 2022;13:992762. [DOI: 10.3389/fimmu.2022.992762] [Reference Citation Analysis]
3 Chen X, Feng J, Chen W, Shao S, Chen L, Wan H. Small extracellular vesicles: from promoting pre-metastatic niche formation to therapeutic strategies in breast cancer. Cell Commun Signal 2022;20:141. [PMID: 36096820 DOI: 10.1186/s12964-022-00945-w] [Reference Citation Analysis]
4 Zhuo S, Yang L, Chen S, Tang C, Li W, Gao Z, Feng J, Yang K. Ferroptosis: A potential opportunity for intervention of pre-metastatic niche. Front Oncol 2022;12:980620. [DOI: 10.3389/fonc.2022.980620] [Reference Citation Analysis]
5 van Geffen C, Heiss C, Deißler A, Kolahian S. Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation. Front Immunol 2022;13:933847. [DOI: 10.3389/fimmu.2022.933847] [Reference Citation Analysis]
6 Chen C, Huang R, Zhou J, Guo L, Xiang S. Formation of pre-metastatic bone niche in prostate cancer and regulation of traditional chinese medicine. Front Pharmacol 2022;13:897942. [DOI: 10.3389/fphar.2022.897942] [Reference Citation Analysis]
7 Ormseth B, Onuma A, Zhang H, Tsung A. The Hepatic Pre-Metastatic Niche. Cancers 2022;14:3731. [DOI: 10.3390/cancers14153731] [Reference Citation Analysis]
8 Cucanic O, Farnsworth RH, Stacker SA. The cellular and molecular mediators of metastasis to the lung. Growth Factors 2022;:1-34. [PMID: 35861197 DOI: 10.1080/08977194.2022.2087520] [Reference Citation Analysis]
9 Bhat AA, Nisar S, Singh M, Ashraf B, Masoodi T, Prasad CP, Sharma A, Maacha S, Karedath T, Hashem S, Yasin SB, Bagga P, Reddy R, Frennaux MP, Uddin S, Dhawan P, Haris M, Macha MA. Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy. Cancer Communications. [DOI: 10.1002/cac2.12295] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zach M. A Complementary Account of Scientific Modelling: Modelling Mechanisms in Cancer Immunology. The British Journal for the Philosophy of Science. [DOI: 10.1086/721530] [Reference Citation Analysis]
11 Pernot S, Evrard S, Khatib AM. The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and Repression. Front Immunol 2022;13:850856. [PMID: 35493456 DOI: 10.3389/fimmu.2022.850856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhao YY, Wang MM, Cui JF. New progress in the mechanism of microenvironment-driven chemoradiotherapy resistance in digestive system tumors. Shijie Huaren Xiaohua Zazhi 2022; 30(8): 341-348 [DOI: 10.11569/wcjd.v30.i8.341] [Reference Citation Analysis]
13 Sellner F, Thalhammer S, Klimpfinger M. Isolated Pancreatic Metastases of Renal Cell Cancer: Genetics and Epigenetics of an Unusual Tumour Entity. Cancers 2022;14:1539. [DOI: 10.3390/cancers14061539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhang Y, Wang G, Li Q, Jiang Y, Chen W, Zhao M, Liang G, Miao Q. Acidity-Activated Charge Conversion of 177Lu-Labeled Nanoagent for the Enhanced Photodynamic Radionuclide Therapy of Cancer. ACS Appl Mater Interfaces 2022;14:3875-84. [PMID: 35021621 DOI: 10.1021/acsami.1c21860] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Cheng JN, Yuan YX, Zhu B, Jia Q. Myeloid-Derived Suppressor Cells: A Multifaceted Accomplice in Tumor Progression. Front Cell Dev Biol 2021;9:740827. [PMID: 35004667 DOI: 10.3389/fcell.2021.740827] [Reference Citation Analysis]
16 Zhu S, Zhao Y, Quan Y, Ma X. Targeting Myeloid-Derived Suppressor Cells Derived From Surgical Stress: The Key to Prevent Post-surgical Metastasis. Front Surg 2021;8:783218. [PMID: 34957205 DOI: 10.3389/fsurg.2021.783218] [Reference Citation Analysis]
17 Ortiz-Espinosa S, Morales X, Senent Y, Alignani D, Tavira B, Macaya I, Ruiz B, Moreno H, Remírez A, Sainz C, Rodriguez-Pena A, Oyarbide A, Ariz M, Andueza MP, Valencia K, Teijeira A, Hoehlig K, Vater A, Rolfe B, Woodruff TM, Lopez-Picazo JM, Vicent S, Kochan G, Escors D, Gil-Bazo I, Perez-Gracia JL, Montuenga LM, Lambris JD, Ortiz de Solorzano C, Lecanda F, Ajona D, Pio R. Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis. Cancer Lett 2021:S0304-3835(21)00644-3. [PMID: 34971753 DOI: 10.1016/j.canlet.2021.12.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 11.0] [Reference Citation Analysis]
18 Bullock K, Richmond A. Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy. Cancers (Basel) 2021;13:6293. [PMID: 34944914 DOI: 10.3390/cancers13246293] [Reference Citation Analysis]
19 Huang YK, Busuttil RA, Boussioutas A. The Role of Innate Immune Cells in Tumor Invasion and Metastasis. Cancers (Basel) 2021;13:5885. [PMID: 34884995 DOI: 10.3390/cancers13235885] [Reference Citation Analysis]
20 Mohammadpour H, MacDonald CR, McCarthy PL, Abrams SI, Repasky EA. β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME. Cell Rep 2021;37:109883. [PMID: 34706232 DOI: 10.1016/j.celrep.2021.109883] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ling Z, Yang C, Tan J, Dou C, Chen Y. Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases. Cell Mol Life Sci 2021;78:7161-83. [PMID: 34635950 DOI: 10.1007/s00018-021-03966-9] [Reference Citation Analysis]
22 Lu Z, Long Y, Li J, Li J, Ren K, Zhao W, Wang X, Xia C, Wang Y, Li M, Zhang Z, He Q. Simultaneous inhibition of breast cancer and its liver and lung metastasis by blocking inflammatory feed-forward loops. J Control Release 2021;338:662-79. [PMID: 34478751 DOI: 10.1016/j.jconrel.2021.08.047] [Reference Citation Analysis]
23 Dong Q, Liu X, Cheng K, Sheng J, Kong J, Liu T. Pre-metastatic Niche Formation in Different Organs Induced by Tumor Extracellular Vesicles. Front Cell Dev Biol 2021;9:733627. [PMID: 34616739 DOI: 10.3389/fcell.2021.733627] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, Shu P, Li D, Wang Y. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther 2021;6:362. [PMID: 34620838 DOI: 10.1038/s41392-021-00670-9] [Reference Citation Analysis]
25 Li Y, He H, Jihu R, Zhou J, Zeng R, Yan H. Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment. Front Cell Dev Biol 2021;9:698532. [PMID: 34527668 DOI: 10.3389/fcell.2021.698532] [Reference Citation Analysis]
26 Miller K, McVeigh CM, Barr EB, Herbert GW, Jacquez Q, Hunter R, Medina S, Lucas SN, Ali AS, Campen MJ, Bolt AM. Inhalation of tungsten metal particulates alters the lung and bone microenvironments following acute exposure. Toxicol Sci 2021:kfab109. [PMID: 34498067 DOI: 10.1093/toxsci/kfab109] [Reference Citation Analysis]
27 DaSilva NA, Barlock BJ, Guha P, Ghosh CC, Trebino CE, Camberg JL, Katz SC, Rowley DC. Proteomic signatures of myeloid derived suppressor cells from liver and lung metastases reveal functional divergence and potential therapeutic targets. Cell Death Discov 2021;7:232. [PMID: 34482371 DOI: 10.1038/s41420-021-00621-x] [Reference Citation Analysis]
28 Lim H, Yang T, Lee W, Park SG. TGF-β Increases MFGE8 Production in Myeloid-Derived Suppressor Cells to Promote B16F10 Melanoma Metastasis. Biomedicines 2021;9:896. [PMID: 34440100 DOI: 10.3390/biomedicines9080896] [Reference Citation Analysis]
29 Gillot L, Baudin L, Rouaud L, Kridelka F, Noël A. The pre-metastatic niche in lymph nodes: formation and characteristics. Cell Mol Life Sci 2021;78:5987-6002. [PMID: 34241649 DOI: 10.1007/s00018-021-03873-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Lee J, Beatty GL. Serum Amyloid A Proteins and Their Impact on Metastasis and Immune Biology in Cancer. Cancers (Basel) 2021;13:3179. [PMID: 34202272 DOI: 10.3390/cancers13133179] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Kapor S, Santibanez JF. Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies. J Clin Med 2021;10:2788. [PMID: 34202907 DOI: 10.3390/jcm10132788] [Reference Citation Analysis]
32 Chen S, Yang X, Zhang Y, Liu Y, Lu H, Qiu Y, Cheng L, Li C, Wang C. Inhalable Porous Microspheres Loaded with Metformin and Docosahexaenoic Acid Suppress Tumor Metastasis by Modulating Premetastatic Niche. Mol Pharm 2021;18:2622-33. [PMID: 34165313 DOI: 10.1021/acs.molpharmaceut.1c00125] [Reference Citation Analysis]
33 Magidey-Klein K, Cooper TJ, Kveler K, Normand R, Zhang T, Timaner M, Raviv Z, James BP, Gazit R, Ronai ZA, Shen-Orr S, Shaked Y. IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells. J Immunother Cancer 2021;9:e002856. [PMID: 34140316 DOI: 10.1136/jitc-2021-002856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
34 Kähkönen TE, Halleen JM, Bernoulli J. Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis. Cells 2021;10:1529. [PMID: 34204474 DOI: 10.3390/cells10061529] [Reference Citation Analysis]
35 Liu Z, Wu X, Tian Y, Zhang W, Qiao S, Xu W, Liu Y, Wang S. H. pylori infection induces CXCL8 expression and promotes gastric cancer progress through downregulating KLF4. Mol Carcinog 2021;60:524-37. [PMID: 34038586 DOI: 10.1002/mc.23309] [Reference Citation Analysis]
36 Gao J, Li S, Xu Q, Zhang X, Huang M, Dai X, Liu L. Exosomes Promote Pre-Metastatic Niche Formation in Gastric Cancer. Front Oncol 2021;11:652378. [PMID: 34109113 DOI: 10.3389/fonc.2021.652378] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Pradhan AK, Maji S, Bhoopathi P, Talukdar S, Mannangatti P, Guo C, Wang XY, Cartagena LC, Idowu M, Landry JW, Sarkar D, Emdad L, Cavenee WK, Das SK, Fisher PB. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β. Proc Natl Acad Sci U S A 2021;118:e2103180118. [PMID: 34016751 DOI: 10.1073/pnas.2103180118] [Reference Citation Analysis]
38 Lu Z, Long Y, Wang Y, Wang X, Xia C, Li M, Zhang Z, He Q. Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression. Eur J Pharm Biopharm 2021;165:164-73. [PMID: 34020022 DOI: 10.1016/j.ejpb.2021.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Zalfa C, Paust S. Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy. Front Immunol 2021;12:633205. [PMID: 34025641 DOI: 10.3389/fimmu.2021.633205] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Hofbauer LC, Bozec A, Rauner M, Jakob F, Perner S, Pantel K. Novel approaches to target the microenvironment of bone metastasis. Nat Rev Clin Oncol 2021;18:488-505. [PMID: 33875860 DOI: 10.1038/s41571-021-00499-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
41 Sellner F, Thalhammer S, Klimpfinger M. Tumour Evolution and Seed and Soil Mechanism in Pancreatic Metastases of Renal Cell Carcinoma. Cancers (Basel) 2021;13:1342. [PMID: 33809634 DOI: 10.3390/cancers13061342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Salemme V, Centonze G, Cavallo F, Defilippi P, Conti L. The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy. Front Oncol 2021;11:610303. [PMID: 33777750 DOI: 10.3389/fonc.2021.610303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
43 Wang M, Zhao X, Huang F, Wang L, Huang J, Gong Z, Yu W. Exosomal proteins: Key players mediating pre‑metastatic niche formation and clinical implications (Review). Int J Oncol 2021;58:4. [PMID: 33649844 DOI: 10.3892/ijo.2021.5184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Talty R, Olino K. Metabolism of Innate Immune Cells in Cancer. Cancers (Basel) 2021;13:904. [PMID: 33670082 DOI: 10.3390/cancers13040904] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
45 Tumino N, Di Pace AL, Besi F, Quatrini L, Vacca P, Moretta L. Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT. Front Immunol 2021;12:638841. [PMID: 33679798 DOI: 10.3389/fimmu.2021.638841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
46 Utrero-Rico A, Laguna-Goya R, Cano-Romero F, Chivite-Lacaba M, Gonzalez-Cuadrado C, Rodríguez-Sánchez E, Ruiz-Hurtado G, Serrano A, Fernández-Ruiz M, Justo I, González E, Andrés A, Paz-Artal E. Early Posttransplant Mobilization of Monocytic Myeloid-derived Suppressor Cell Correlates With Increase in Soluble Immunosuppressive Factors and Predicts Cancer in Kidney Recipients. Transplantation 2020;104:2599-608. [PMID: 32068661 DOI: 10.1097/TP.0000000000003179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Oh MH, Sun IH, Zhao L, Leone RD, Sun IM, Xu W, Collins SL, Tam AJ, Blosser RL, Patel CH, Englert JM, Arwood ML, Wen J, Chan-Li Y, Tenora L, Majer P, Rais R, Slusher BS, Horton MR, Powell JD. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells. J Clin Invest 2020;130:3865-84. [PMID: 32324593 DOI: 10.1172/JCI131859] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 43.0] [Reference Citation Analysis]
48 Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol 2021;21:485-98. [PMID: 33526920 DOI: 10.1038/s41577-020-00490-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 51] [Article Influence: 41.0] [Reference Citation Analysis]
49 Cartwright ANR, Suo S, Badrinath S, Kumar S, Melms J, Luoma A, Bagati A, Saadatpour A, Izar B, Yuan GC, Wucherpfennig KW. Immunosuppressive Myeloid Cells Induce Nitric Oxide-Dependent DNA Damage and p53 Pathway Activation in CD8+ T Cells. Cancer Immunol Res 2021;9:470-85. [PMID: 33514509 DOI: 10.1158/2326-6066.CIR-20-0085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
50 Ma C, Zhang Q, Greten TF. MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target. Cell Immunol 2021;361:104295. [PMID: 33508529 DOI: 10.1016/j.cellimm.2021.104295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
51 Väyrynen SA, Zhang J, Yuan C, Väyrynen JP, Dias Costa A, Williams H, Morales-Oyarvide V, Lau MC, Rubinson DA, Dunne RF, Kozak MM, Wang W, Agostini-Vulaj D, Drage MG, Brais L, Reilly E, Rahma O, Clancy T, Wang J, Linehan DC, Aguirre AJ, Fuchs CS, Coussens LM, Chang DT, Koong AC, Hezel AF, Ogino S, Nowak JA, Wolpin BM. Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer. Clin Cancer Res 2021;27:1069-81. [PMID: 33262135 DOI: 10.1158/1078-0432.CCR-20-3141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Yang P, Hu Y, Zhou Q. The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer. Curr Med Chem 2020;27:5543-61. [PMID: 31724498 DOI: 10.2174/0929867326666191113113110] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
53 Li W, Su Z, Hao M, Ju C, Zhang C. Cytopharmaceuticals: An emerging paradigm for drug delivery. Journal of Controlled Release 2020;328:313-24. [DOI: 10.1016/j.jconrel.2020.08.063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
54 Yang L, Li T, Shi H, Zhou Z, Huang Z, Lei X. The cellular and molecular components involved in pre-metastatic niche formation in colorectal cancer liver metastasis. Expert Review of Gastroenterology & Hepatology 2021;15:389-99. [DOI: 10.1080/17474124.2021.1848543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Tang F, Tie Y, Hong W, Wei Y, Tu C, Wei X. Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection. Ann Surg Oncol 2021;28:4030-48. [PMID: 33258011 DOI: 10.1245/s10434-020-09371-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
56 Shang C, Qiao J, Guo H. The dynamic behavior of lipid droplets in the pre-metastatic niche. Cell Death Dis 2020;11:990. [PMID: 33203856 DOI: 10.1038/s41419-020-03207-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Guccini I, Revandkar A, D'Ambrosio M, Colucci M, Pasquini E, Mosole S, Troiani M, Brina D, Sheibani-Tezerji R, Elia AR, Rinaldi A, Pernigoni N, Rüschoff JH, Dettwiler S, De Marzo AM, Antonarakis ES, Borrelli C, Moor AE, Garcia-Escudero R, Alajati A, Attanasio G, Losa M, Moch H, Wild P, Egger G, Alimonti A. Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis. Cancer Cell 2021;39:68-82.e9. [PMID: 33186519 DOI: 10.1016/j.ccell.2020.10.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
58 Sacchi A, Grassi G, Bordoni V, Lorenzini P, Cimini E, Casetti R, Tartaglia E, Marchioni L, Petrosillo N, Palmieri F, D'Offizi G, Notari S, Tempestilli M, Capobianchi MR, Nicastri E, Maeurer M, Zumla A, Locatelli F, Antinori A, Ippolito G, Agrati C. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis 2020;11:921. [PMID: 33110074 DOI: 10.1038/s41419-020-03125-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 9.5] [Reference Citation Analysis]
59 Deng L, Li T, Liao Y, Liu S, Xie Z, Huang Z, Dai H, Li J, Lei X. Peritumoral activated hepatic stellate cells are associated with hepatic recurrence for resectable colorectal adenocarcinoma liver metastasis following resection. Oncol Lett 2020;20:287. [PMID: 33014165 DOI: 10.3892/ol.2020.12150] [Reference Citation Analysis]
60 Davidov V, Jensen G, Mai S, Chen SH, Pan PY. Analyzing One Cell at a TIME: Analysis of Myeloid Cell Contributions in the Tumor Immune Microenvironment. Front Immunol 2020;11:1842. [PMID: 32983100 DOI: 10.3389/fimmu.2020.01842] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
61 Fane M, Weeraratna AT. Normal Aging and Its Role in Cancer Metastasis. Cold Spring Harb Perspect Med 2020;10:a037341. [PMID: 31615864 DOI: 10.1101/cshperspect.a037341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
62 Han P, Cao P, Hu S, Kong K, Deng Y, Zhao B, Li F. Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche. Cancer Manag Res 2020;12:5857-79. [PMID: 32765088 DOI: 10.2147/CMAR.S258215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
63 Zhou Y, Han M, Gao J. Prognosis and targeting of pre-metastatic niche. J Control Release 2020;325:223-34. [PMID: 32629136 DOI: 10.1016/j.jconrel.2020.06.037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
64 Rogovskii V. Modulation of Inflammation-Induced Tolerance in Cancer. Front Immunol 2020;11:1180. [PMID: 32676076 DOI: 10.3389/fimmu.2020.01180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Tian S, Song X, Wang Y, Wang X, Mou Y, Chen Q, Zhao H, Ma K, Wu Z, Yu H, Han X, Wang H, Wang S, Ji X, Zhang Y. Chinese herbal medicine Baoyuan Jiedu decoction inhibits the accumulation of myeloid derived suppressor cells in pre-metastatic niche of lung via TGF-β/CCL9 pathway. Biomed Pharmacother 2020;129:110380. [PMID: 32554250 DOI: 10.1016/j.biopha.2020.110380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
66 Sellner F. Isolated Pancreatic Metastases of Renal Cell Carcinoma-A Paradigm of a Seed and Soil Mechanism: A Literature Analysis of 1,034 Observations. Front Oncol 2020;10:709. [PMID: 32547940 DOI: 10.3389/fonc.2020.00709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Raskov H, Orhan A, Salanti A, Gögenur I. Premetastatic niches, exosomes and circulating tumor cells: Early mechanisms of tumor dissemination and the relation to surgery. Int J Cancer 2020;146:3244-55. [PMID: 31808150 DOI: 10.1002/ijc.32820] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
68 Vetsika EK, Koukos A, Kotsakis A. Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer. Cells 2019;8:E1647. [PMID: 31847487 DOI: 10.3390/cells8121647] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
69 Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression. Nat Rev Cancer 2020;20:89-106. [PMID: 31836838 DOI: 10.1038/s41568-019-0222-9] [Cited by in Crossref: 105] [Cited by in F6Publishing: 100] [Article Influence: 35.0] [Reference Citation Analysis]
70 Long Y, Lu Z, Xu S, Li M, Wang X, Zhang Z, He Q. Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells. Nano Lett 2020;20:2219-29. [DOI: 10.1021/acs.nanolett.9b03883] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 8.7] [Reference Citation Analysis]
71 DeVito NC, Plebanek MP, Theivanthiran B, Hanks BA. Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion. Front Immunol 2019;10:2876. [PMID: 31921140 DOI: 10.3389/fimmu.2019.02876] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
72 Francisco BJ, Palumbo JS. New insights into cancer's exploitation of platelets. J Thromb Haemost 2019;17:2000-3. [PMID: 31797541 DOI: 10.1111/jth.14624] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
73 Paolillo M, Schinelli S. Extracellular Matrix Alterations in Metastatic Processes. Int J Mol Sci. 2019;20. [PMID: 31591367 DOI: 10.3390/ijms20194947] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 21.3] [Reference Citation Analysis]
74 Sellner F. Observations on Solitary Versus Multiple Isolated Pancreatic Metastases of Renal Cell Carcinoma: Another Indication of a Seed and Soil Mechanism? Cancers (Basel) 2019;11:E1379. [PMID: 31533220 DOI: 10.3390/cancers11091379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
75 Audrito V, Managò A, Gaudino F, Sorci L, Messana VG, Raffaelli N, Deaglio S. NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer. Front Immunol 2019;10:1720. [PMID: 31402913 DOI: 10.3389/fimmu.2019.01720] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
76 Albonici L, Giganti MG, Modesti A, Manzari V, Bei R. Multifaceted Role of the Placental Growth Factor (PlGF) in the Antitumor Immune Response and Cancer Progression. Int J Mol Sci 2019;20:E2970. [PMID: 31216652 DOI: 10.3390/ijms20122970] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]